Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
25 studies found for:    Reye's Syndrome
Show Display Options
Rank Status Study
1 Recruiting Intracranial Hypertension and Optic Nerve Sheath Diameter
Conditions: Cerebral Stroke;   Cerebral Venous Thrombosis
Intervention: Other: ONSD ultrasound
2 Recruiting Restless Leg Syndrome and Severe Preeclampsia
Conditions: Restless Leg Syndrome;   Severe Preeclampsia
Intervention:
3 Completed Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women
Conditions: Pregestational Obesity (BMI > 27kg/m2);   History of Polycystic Ovary Syndrome
Interventions: Drug: medical nutrition therapy + metformin;   Behavioral: Medical nutrition therapy
4 Completed Amniotic Fluid Optical Density Determination as a Test for Assessment of Fetal Lung Maturity.
Condition: Respiratory Distress Syndrome, Newborn
Intervention: Procedure: Preterm fetus
5 Not yet recruiting Antiphospholipid Antibodies and Fetal Growth Restriction
Conditions: Fetal Growth Restriction;   Antiphospholipid Syndrome
Intervention:
6 Not yet recruiting Antiphospholipid Antibodies and Early Severe Preeclampsia.
Conditions: Severe Preeclampsia;   Antiphospholipid Syndrome
Intervention:
7 Completed Colloids in Severe Trauma
Conditions: Abdominal Hypertension;   Abdominal Compartment Syndrome;   Severe Trauma
Intervention: Drug: tetrastarch (Voluven)
8 Terminated L-Arginine and Antioxidant Vitamins During Pregnancy to Reduce Preeclampsia
Condition: Pre-Eclampsia
Interventions: Procedure: L-arginine supplementation in a medical food;   Procedure: Vitamin C and E supplementation in a medical food
9 Terminated Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment
Conditions: HIV;   AIDS;   Tuberculosis
Interventions: Drug: Simultaneous ARV and antiMTB;   Drug: Deferred RV and antiMTB treatment
10 Recruiting Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients
Conditions: Polycystic Ovary Syndrome;   Obesity
Interventions: Drug: Metformin;   Dietary Supplement: Magnesium;   Dietary Supplement: PUFA
11 Not yet recruiting A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Conditions: Cow's Milk Protein Allergy;   Eosinophilic Gastrointestinal Disorders;   Malabsorption/Maldigestion;   Short Bowel Syndrome;   Multiple Food Allergies
Intervention: Other: Free amino acid infant formula
12 Recruiting Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Belimumab;   Drug: Rituximab;   Drug: Placebo belimumab;   Drug: Placebo rituximab
13 Terminated
Has Results
Phase III Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: Apixaban;   Drug: Placebo
14 Recruiting ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab
Condition: Acute Coronary Syndrome
Interventions: Drug: alirocumab;   Drug: Placebo
15 Unknown  PI Vs. NNRTI Based Therapy for HIV Advanced Disease
Condition: Acquired Immunodeficiency Syndrome
Interventions: Drug: zidovudine+lamivudine+lopinavir/ritonavir;   Drug: zidovudine + lamivudine + efavirenz
16 Completed Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge
Conditions: ACS;   Acute Coronary Syndrome;   Myocardial Infarction;   Unstable Angina;   Coronary Artery Disease
Intervention:
17 Completed The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
Condition: Acute Coronary Syndrome
Interventions: Drug: Darapladib 160 mg;   Drug: Placebo;   Other: Standard Therapy
18 Completed A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Aleglitazar;   Drug: Placebo
19 Completed
Has Results
Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
Condition: Kaposi´s Sarcoma
Intervention: Drug: Bevacizumab
20 Completed Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)
Condition: Prostatic Cancer
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.